-
Mar 13, 2024 | 
raskmedia.com.au | Daniel Ortisi |James Gerrish
Daniel Ortisi of Stock Doctor gives us a detailed pre-market commentary on the results of popular small cap RPMGlobal Holdings Ltd (ASX: RUL). Is RUL share price a buy today? Mining advisory and software business RPM Global announced its 1H24 result which appears in line with management’s updated FY24 guidance. As RUL is passing the inflection point between loss making and profitability, we can see large variations in its bottom-line result.
-
Dec 13, 2023 | 
raskmedia.com.au | James Gerrish |Daniel Ortisi |Jaz Harrison |action. He
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +1.65% to 7,377.90. Markets @ Midday: Listen here at lunchtime or find all Market Matters Podcasts on Spotify.
-
Dec 13, 2023 | 
raskmedia.com.au | Daniel Ortisi |Jaz Harrison |James Dunn
Daniel Ortisi of Stock Doctor shares a glimpse into the operations, drivers and potential risks of XRF Scientific Limited (ASX: XRF). Is XRF share price a buy today? Recently, our analyst team visited the executives of XRF Scientific Limited at their Melbourne precious metals labware manufacturing facility. This visit offered an insightful glimpse into the operations, drivers and potential risks of the business.
-
Dec 8, 2023 | 
raskmedia.com.au | Daniel Ortisi |Ron Shamgar |James Dunn
Drinks and hotels business Endeavour Group Ltd (ASX: EDV) recently held its Investor Day. The Analyst Team at Stock Doctor has provided an updated review of Endeavour Group, including our thoughts as to why the stock may be an undervalued opportunity for long-term investors.
-
Nov 29, 2023 | 
raskmedia.com.au | Daniel Ortisi |James Gerrish |Ron Shamgar
There are a lot of yield traps in the share market and understanding yield traps is an important step. Daniel Ortisi of Stock Doctor tells us how to avoid yield traps, with Peter Warren Automotive Holdings Ltd (ASX: PWR), Telstra Group Ltd (ASX: TLS), APA Group (ASX: APA), and Commonwealth Bank of Australia (ASX: CBA) as key examples. As an investor, it is crucial to differentiate attractive dividend-paying stocks and yield traps. What is a yield trap?
-
Nov 5, 2023 | 
raskmedia.com.au | Drew Meredith |Jaz Harrison |James Gerrish |Daniel Ortisi
Signs that US interest rates could remain on hold boosted the Australian share market on Friday, with the All Ordinaries (INDEXASX: XAO) and S&P/ASX 200 (INDEXASX: XJO) both gaining 1.1% with the energy sector the only detractor. The most interest rate sensitive sectors, being property, industrials and healthcare all gained strongly, adding more than 2% each, with Charter Hall Group (ASX: CHC) and Scentre Group (ASX: SCG) adding 3.7% and 4.5% as lower rates mean stronger property valuations.
-
Nov 2, 2023 | 
raskmedia.com.au | James Gerrish |Daniel Ortisi |Drew Meredith |Jaz Harrison
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +1.14% to 6978.20. Markets @ Midday: Listen here at lunchtime or find all Market Matters Podcasts on Spotify.
-
Nov 2, 2023 | 
raskmedia.com.au | Daniel Ortisi |Drew Meredith |Jaz Harrison
Members of the Stock Doctor analyst team attended the Trajan Group Holdings Ltd (ASX: TRJ) inaugural shareholder day on Monday the 30th of October. This gave us an opportunity to further understand the business, meet management and visit its manufacturing facility in Ringwood, Melbourne. Trajan is not currently a star stock as it doesn’t meet our criteria under Golden Rules 2&3.
-
Oct 25, 2023 | 
raskmedia.com.au | James Gerrish |Jaz Harrison |Daniel Ortisi
The Nasdaq Composite Index is a stock index that reflects the changes of the NASDAQ stock market. Nasdaq-listed companies cover all new technology industries, including software and computers, telecommunications, biotechnology, retail and wholesale trading.
-
Oct 24, 2023 | 
raskmedia.com.au | Daniel Ortisi |Jaz Harrison |Owen Raszkiewicz |James Dunn
Our team at Stock Doctor have been providing bottom-up, high-quality equity research to self-directed Australian investors for decades and we’re offering you FREE access to our platform for 14 days. We are currently in the trenches of reporting season and will be providing tons of content for those investors who are struggling to find opportunities in this market.
